

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.17316068 |
| 2 | negative regulation of telomere maintenance (GO:0032205) | 5.17940954 |
| 3 | detection of light stimulus involved in visual perception (GO:0050908) | 4.87544129 |
| 4 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.87544129 |
| 5 | response to pheromone (GO:0019236) | 4.48341815 |
| 6 | DNA deamination (GO:0045006) | 4.47023351 |
| 7 | mitotic cell cycle arrest (GO:0071850) | 4.26964054 |
| 8 | cellular response to ATP (GO:0071318) | 4.22523347 |
| 9 | negative regulation of cell aging (GO:0090344) | 4.08355184 |
| 10 | respiratory chain complex IV assembly (GO:0008535) | 3.83126889 |
| 11 | L-fucose catabolic process (GO:0042355) | 3.82995338 |
| 12 | fucose catabolic process (GO:0019317) | 3.82995338 |
| 13 | L-fucose metabolic process (GO:0042354) | 3.82995338 |
| 14 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.77147257 |
| 15 | piRNA metabolic process (GO:0034587) | 3.62938775 |
| 16 | axoneme assembly (GO:0035082) | 3.58708044 |
| 17 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.56175378 |
| 18 | NADH dehydrogenase complex assembly (GO:0010257) | 3.56175378 |
| 19 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.56175378 |
| 20 | meiotic chromosome segregation (GO:0045132) | 3.55757831 |
| 21 | protein complex biogenesis (GO:0070271) | 3.53134401 |
| 22 | regulation of telomere maintenance (GO:0032204) | 3.49744361 |
| 23 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.48827594 |
| 24 | transepithelial transport (GO:0070633) | 3.48203239 |
| 25 | cytochrome complex assembly (GO:0017004) | 3.45953427 |
| 26 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.38267728 |
| 27 | DNA damage induced protein phosphorylation (GO:0006975) | 3.36992866 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 3.35482656 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 3.35482656 |
| 30 | tryptophan catabolic process (GO:0006569) | 3.35482656 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 3.28972550 |
| 32 | positive regulation of heat generation (GO:0031652) | 3.28284469 |
| 33 | epithelial cilium movement (GO:0003351) | 3.25649969 |
| 34 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.24450992 |
| 35 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.19610204 |
| 36 | cornea development in camera-type eye (GO:0061303) | 3.15465449 |
| 37 | kynurenine metabolic process (GO:0070189) | 3.13353153 |
| 38 | mannosylation (GO:0097502) | 3.11701807 |
| 39 | peptidyl-histidine modification (GO:0018202) | 3.09776450 |
| 40 | rRNA catabolic process (GO:0016075) | 3.08640812 |
| 41 | indolalkylamine metabolic process (GO:0006586) | 3.08638079 |
| 42 | reciprocal DNA recombination (GO:0035825) | 3.08518879 |
| 43 | reciprocal meiotic recombination (GO:0007131) | 3.08518879 |
| 44 | pseudouridine synthesis (GO:0001522) | 3.07655782 |
| 45 | estrogen biosynthetic process (GO:0006703) | 3.05288351 |
| 46 | protein-cofactor linkage (GO:0018065) | 3.01454205 |
| 47 | ketone body metabolic process (GO:1902224) | 3.01271185 |
| 48 | regulation of heat generation (GO:0031650) | 3.00544151 |
| 49 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.99535927 |
| 50 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.98982877 |
| 51 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.98973691 |
| 52 | platelet dense granule organization (GO:0060155) | 2.98780326 |
| 53 | DNA strand renaturation (GO:0000733) | 2.96580773 |
| 54 | GPI anchor metabolic process (GO:0006505) | 2.88537913 |
| 55 | negative regulation of telomerase activity (GO:0051974) | 2.86237734 |
| 56 | DNA methylation involved in gamete generation (GO:0043046) | 2.85125713 |
| 57 | positive regulation of defense response to virus by host (GO:0002230) | 2.84163292 |
| 58 | multicellular organism reproduction (GO:0032504) | 2.83582312 |
| 59 | tryptophan metabolic process (GO:0006568) | 2.82757093 |
| 60 | protein import into peroxisome matrix (GO:0016558) | 2.80236664 |
| 61 | regulation of synapse structural plasticity (GO:0051823) | 2.79621713 |
| 62 | protein polyglutamylation (GO:0018095) | 2.77070218 |
| 63 | cilium movement (GO:0003341) | 2.76507799 |
| 64 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.74425491 |
| 65 | sulfation (GO:0051923) | 2.73215789 |
| 66 | maturation of 5.8S rRNA (GO:0000460) | 2.72455303 |
| 67 | C-terminal protein lipidation (GO:0006501) | 2.71557418 |
| 68 | regulation of skeletal muscle contraction (GO:0014819) | 2.66085162 |
| 69 | cilium morphogenesis (GO:0060271) | 2.65752992 |
| 70 | replication fork processing (GO:0031297) | 2.64744701 |
| 71 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.64417986 |
| 72 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63034439 |
| 73 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.62205970 |
| 74 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.62205970 |
| 75 | positive regulation of prostaglandin secretion (GO:0032308) | 2.61071206 |
| 76 | exogenous drug catabolic process (GO:0042738) | 2.60193873 |
| 77 | synaptic transmission, cholinergic (GO:0007271) | 2.59995095 |
| 78 | protein localization to cilium (GO:0061512) | 2.59347901 |
| 79 | spinal cord motor neuron differentiation (GO:0021522) | 2.59239136 |
| 80 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.56712202 |
| 81 | C-terminal protein amino acid modification (GO:0018410) | 2.56314888 |
| 82 | cellular biogenic amine catabolic process (GO:0042402) | 2.54262824 |
| 83 | amine catabolic process (GO:0009310) | 2.54262824 |
| 84 | neuronal action potential (GO:0019228) | 2.54180062 |
| 85 | tRNA modification (GO:0006400) | 2.52080206 |
| 86 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.50851944 |
| 87 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.50851944 |
| 88 | glycerophospholipid catabolic process (GO:0046475) | 2.48932917 |
| 89 | photoreceptor cell development (GO:0042461) | 2.48858059 |
| 90 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.48781745 |
| 91 | GPI anchor biosynthetic process (GO:0006506) | 2.45812407 |
| 92 | fucosylation (GO:0036065) | 2.45242408 |
| 93 | tRNA processing (GO:0008033) | 2.44618745 |
| 94 | recombinational repair (GO:0000725) | 2.43245157 |
| 95 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.42780591 |
| 96 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.42559227 |
| 97 | double-strand break repair via homologous recombination (GO:0000724) | 2.41867367 |
| 98 | positive regulation of fatty acid transport (GO:2000193) | 2.40488668 |
| 99 | negative regulation of mast cell activation (GO:0033004) | 2.40289265 |
| 100 | regulation of action potential (GO:0098900) | 2.40033696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.55807739 |
| 2 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.78241462 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47444785 |
| 4 | EWS_26573619_Chip-Seq_HEK293_Human | 2.45855794 |
| 5 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.45345746 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.38081593 |
| 7 | FUS_26573619_Chip-Seq_HEK293_Human | 2.27591139 |
| 8 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.24150482 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20760682 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.18978721 |
| 11 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 2.14396923 |
| 12 | TP53_22573176_ChIP-Seq_HFKS_Human | 2.08169667 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.98121453 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95439438 |
| 15 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.94861860 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91427726 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.84916971 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.84888807 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81758812 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80583716 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76212580 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75735820 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74036606 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73045198 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.72326485 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.69963742 |
| 27 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.64979064 |
| 28 | ERA_21632823_ChIP-Seq_H3396_Human | 1.63956915 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57049735 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52851629 |
| 31 | NCOR_22424771_ChIP-Seq_293T_Human | 1.50590057 |
| 32 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.50586485 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.48337625 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.47395914 |
| 35 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.46897052 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45332597 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45332597 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45086992 |
| 39 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.44446989 |
| 40 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.44333535 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43772593 |
| 42 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.43150724 |
| 43 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.43150724 |
| 44 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.41672633 |
| 45 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.41167457 |
| 46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.40978068 |
| 47 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.40016296 |
| 48 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38781155 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.38265322 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36678873 |
| 51 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.35831666 |
| 52 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.33779824 |
| 53 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.31370027 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.30067449 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28646207 |
| 56 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.26485068 |
| 57 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.26207940 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26189774 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25509266 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25493993 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25138712 |
| 62 | AR_20517297_ChIP-Seq_VCAP_Human | 1.24848009 |
| 63 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.23629161 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22497589 |
| 65 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22253804 |
| 66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20461469 |
| 67 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18826575 |
| 68 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18826575 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17695644 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16620882 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16578710 |
| 72 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14592920 |
| 73 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14592920 |
| 74 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13852941 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13269129 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12040203 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11832473 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08938655 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08818537 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07883782 |
| 81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07775724 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07365970 |
| 83 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.06882419 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06866370 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06284544 |
| 86 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.05140701 |
| 87 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05065936 |
| 88 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04898300 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04402210 |
| 90 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.03933954 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03794881 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03154223 |
| 93 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.02195131 |
| 94 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.02183274 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01402311 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01363169 |
| 97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00192814 |
| 98 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99730105 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98464616 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98324819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 3.44372060 |
| 2 | MP0005174_abnormal_tail_pigmentation | 3.35338086 |
| 3 | MP0001986_abnormal_taste_sensitivity | 3.18351846 |
| 4 | MP0005171_absent_coat_pigmentation | 2.79068231 |
| 5 | MP0005551_abnormal_eye_electrophysiolog | 2.66372294 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.64108245 |
| 7 | MP0003195_calcinosis | 2.50184061 |
| 8 | MP0002102_abnormal_ear_morphology | 2.44344468 |
| 9 | MP0003136_yellow_coat_color | 2.39279338 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.35775757 |
| 11 | MP0004147_increased_porphyrin_level | 2.17839171 |
| 12 | MP0002736_abnormal_nociception_after | 2.02639448 |
| 13 | MP0004043_abnormal_pH_regulation | 2.01377281 |
| 14 | MP0002163_abnormal_gland_morphology | 1.97730425 |
| 15 | MP0005423_abnormal_somatic_nervous | 1.95760181 |
| 16 | MP0003880_abnormal_central_pattern | 1.95659531 |
| 17 | MP0002876_abnormal_thyroid_physiology | 1.92765868 |
| 18 | MP0005253_abnormal_eye_physiology | 1.91626905 |
| 19 | MP0006292_abnormal_olfactory_placode | 1.84643726 |
| 20 | MP0008872_abnormal_physiological_respon | 1.83715548 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.77083524 |
| 22 | MP0009745_abnormal_behavioral_response | 1.74943419 |
| 23 | MP0001919_abnormal_reproductive_system | 1.74821316 |
| 24 | MP0003787_abnormal_imprinting | 1.73707771 |
| 25 | MP0002254_reproductive_system_inflammat | 1.72760600 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.71089457 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 1.70905020 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.67650590 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.63951508 |
| 30 | MP0002160_abnormal_reproductive_system | 1.61986525 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.59599279 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.56168232 |
| 33 | MP0004133_heterotaxia | 1.55549189 |
| 34 | MP0003646_muscle_fatigue | 1.54441277 |
| 35 | MP0005410_abnormal_fertilization | 1.54219795 |
| 36 | MP0009046_muscle_twitch | 1.51626124 |
| 37 | MP0000427_abnormal_hair_cycle | 1.50555418 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.47724461 |
| 39 | MP0005389_reproductive_system_phenotype | 1.47296338 |
| 40 | MP0000015_abnormal_ear_pigmentation | 1.46965501 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.43137876 |
| 42 | MP0002938_white_spotting | 1.39393236 |
| 43 | MP0005379_endocrine/exocrine_gland_phen | 1.38890015 |
| 44 | MP0004885_abnormal_endolymph | 1.37503874 |
| 45 | MP0000631_abnormal_neuroendocrine_gland | 1.32824672 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.32729747 |
| 47 | MP0005332_abnormal_amino_acid | 1.31905473 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.31819888 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.31781406 |
| 50 | MP0001529_abnormal_vocalization | 1.31653843 |
| 51 | MP0001970_abnormal_pain_threshold | 1.28462530 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.27570401 |
| 53 | MP0002272_abnormal_nervous_system | 1.25604855 |
| 54 | MP0004142_abnormal_muscle_tone | 1.24321864 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.19369743 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.13494163 |
| 57 | MP0001324_abnormal_eye_pigmentation | 1.12354333 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.11095696 |
| 59 | MP0002064_seizures | 1.10211536 |
| 60 | MP0005195_abnormal_posterior_eye | 1.07981198 |
| 61 | MP0001661_extended_life_span | 1.05589523 |
| 62 | MP0002095_abnormal_skin_pigmentation | 1.05310156 |
| 63 | MP0004924_abnormal_behavior | 1.04362977 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.04362977 |
| 65 | MP0001756_abnormal_urination | 1.03471768 |
| 66 | MP0005083_abnormal_biliary_tract | 1.02470169 |
| 67 | MP0008058_abnormal_DNA_repair | 0.99746046 |
| 68 | MP0002928_abnormal_bile_duct | 0.98916265 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.98366375 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 0.97736294 |
| 71 | MP0002557_abnormal_social/conspecific_i | 0.96745461 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.95064847 |
| 73 | MP0002653_abnormal_ependyma_morphology | 0.93000568 |
| 74 | MP0002751_abnormal_autonomic_nervous | 0.89888048 |
| 75 | MP0001486_abnormal_startle_reflex | 0.89829095 |
| 76 | MP0001501_abnormal_sleep_pattern | 0.89706236 |
| 77 | MP0000470_abnormal_stomach_morphology | 0.87466549 |
| 78 | MP0000647_abnormal_sebaceous_gland | 0.86942619 |
| 79 | MP0003635_abnormal_synaptic_transmissio | 0.86940018 |
| 80 | MP0001764_abnormal_homeostasis | 0.86223049 |
| 81 | MP0003718_maternal_effect | 0.85804209 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.84270542 |
| 83 | MP0001188_hyperpigmentation | 0.83679459 |
| 84 | MP0001905_abnormal_dopamine_level | 0.83474607 |
| 85 | MP0002210_abnormal_sex_determination | 0.82982119 |
| 86 | MP0003698_abnormal_male_reproductive | 0.82257790 |
| 87 | MP0008995_early_reproductive_senescence | 0.79914483 |
| 88 | MP0004742_abnormal_vestibular_system | 0.79487393 |
| 89 | MP0005365_abnormal_bile_salt | 0.78654687 |
| 90 | MP0002063_abnormal_learning/memory/cond | 0.77973444 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.77702896 |
| 92 | MP0003011_delayed_dark_adaptation | 0.77583540 |
| 93 | MP0005671_abnormal_response_to | 0.76747084 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.76604923 |
| 95 | MP0002734_abnormal_mechanical_nocicepti | 0.75669450 |
| 96 | MP0002067_abnormal_sensory_capabilities | 0.75184825 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.75061002 |
| 98 | MP0002909_abnormal_adrenal_gland | 0.74794095 |
| 99 | MP0001929_abnormal_gametogenesis | 0.74442084 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.74000952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 4.61639215 |
| 2 | Attenuation of retinal blood vessels (HP:0007843) | 4.48248889 |
| 3 | Abnormality of midbrain morphology (HP:0002418) | 3.92284207 |
| 4 | Molar tooth sign on MRI (HP:0002419) | 3.92284207 |
| 5 | Pancreatic cysts (HP:0001737) | 3.77152296 |
| 6 | Chronic hepatic failure (HP:0100626) | 3.55669447 |
| 7 | Lipid accumulation in hepatocytes (HP:0006561) | 3.53064773 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 3.48670286 |
| 9 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.45506656 |
| 10 | Nephronophthisis (HP:0000090) | 3.43615230 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.41273483 |
| 12 | Rib fusion (HP:0000902) | 3.40912236 |
| 13 | Hyperventilation (HP:0002883) | 3.35734224 |
| 14 | Mesangial abnormality (HP:0001966) | 3.27887077 |
| 15 | Decreased central vision (HP:0007663) | 3.27331665 |
| 16 | True hermaphroditism (HP:0010459) | 3.26340285 |
| 17 | Polydipsia (HP:0001959) | 3.21824858 |
| 18 | Abnormal drinking behavior (HP:0030082) | 3.21824858 |
| 19 | Renal Fanconi syndrome (HP:0001994) | 3.08494197 |
| 20 | Type II lissencephaly (HP:0007260) | 3.06887227 |
| 21 | Testicular atrophy (HP:0000029) | 2.99504611 |
| 22 | Abnormality of the renal medulla (HP:0100957) | 2.93876835 |
| 23 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.88669519 |
| 24 | Mitochondrial inheritance (HP:0001427) | 2.82353454 |
| 25 | Increased CSF lactate (HP:0002490) | 2.79237550 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.78729703 |
| 27 | Dyschromatopsia (HP:0007641) | 2.78382921 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.76386614 |
| 29 | Pendular nystagmus (HP:0012043) | 2.75353860 |
| 30 | Abnormality of the renal cortex (HP:0011035) | 2.62987693 |
| 31 | Tubular atrophy (HP:0000092) | 2.61166417 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.59464299 |
| 33 | Patellar aplasia (HP:0006443) | 2.55849552 |
| 34 | Polyuria (HP:0000103) | 2.55514024 |
| 35 | Chorioretinal atrophy (HP:0000533) | 2.53290883 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.51519601 |
| 37 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.43684969 |
| 38 | Cerebellar dysplasia (HP:0007033) | 2.40104824 |
| 39 | Exertional dyspnea (HP:0002875) | 2.31768917 |
| 40 | Hypoalbuminemia (HP:0003073) | 2.29774783 |
| 41 | Abnormal albumin level (HP:0012116) | 2.29774783 |
| 42 | Inability to walk (HP:0002540) | 2.25455188 |
| 43 | Cystic liver disease (HP:0006706) | 2.25143206 |
| 44 | Optic disc pallor (HP:0000543) | 2.20507564 |
| 45 | Medial flaring of the eyebrow (HP:0010747) | 2.17716597 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.17448270 |
| 47 | Hyperalaninemia (HP:0003348) | 2.17448270 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.17448270 |
| 49 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.15589388 |
| 50 | Decreased circulating renin level (HP:0003351) | 2.13147088 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.12801219 |
| 52 | Abnormality of the pons (HP:0007361) | 2.12145157 |
| 53 | Hepatic necrosis (HP:0002605) | 2.11591356 |
| 54 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.10053086 |
| 55 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.09869776 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09840219 |
| 57 | Increased serum lactate (HP:0002151) | 2.08979268 |
| 58 | Progressive inability to walk (HP:0002505) | 2.07746739 |
| 59 | Lissencephaly (HP:0001339) | 2.04189363 |
| 60 | Abnormal urine output (HP:0012590) | 2.02690791 |
| 61 | Rectal fistula (HP:0100590) | 2.02489181 |
| 62 | Rectovaginal fistula (HP:0000143) | 2.02489181 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 1.97005317 |
| 64 | Hypoplasia of the fovea (HP:0007750) | 1.96081765 |
| 65 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.96081765 |
| 66 | Hypoplasia of the pons (HP:0012110) | 1.95333261 |
| 67 | Facial diplegia (HP:0001349) | 1.94905167 |
| 68 | Increased muscle lipid content (HP:0009058) | 1.91938979 |
| 69 | Absent speech (HP:0001344) | 1.90518300 |
| 70 | Methylmalonic aciduria (HP:0012120) | 1.90406027 |
| 71 | Absent thumb (HP:0009777) | 1.89570445 |
| 72 | Abnormal biliary tract physiology (HP:0012439) | 1.89292873 |
| 73 | Bile duct proliferation (HP:0001408) | 1.89292873 |
| 74 | Congenital hepatic fibrosis (HP:0002612) | 1.89073557 |
| 75 | 3-Methylglutaconic aciduria (HP:0003535) | 1.88534931 |
| 76 | Poikiloderma (HP:0001029) | 1.85704531 |
| 77 | Severe muscular hypotonia (HP:0006829) | 1.84301332 |
| 78 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83085289 |
| 79 | Abnormality of renal resorption (HP:0011038) | 1.82986049 |
| 80 | Large for gestational age (HP:0001520) | 1.81967663 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 1.80811450 |
| 82 | Severe visual impairment (HP:0001141) | 1.79387579 |
| 83 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78084724 |
| 84 | Respiratory difficulties (HP:0002880) | 1.76990659 |
| 85 | Squamous cell carcinoma (HP:0002860) | 1.74394338 |
| 86 | Fair hair (HP:0002286) | 1.73978503 |
| 87 | Glycosuria (HP:0003076) | 1.73664182 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 1.73664182 |
| 89 | Sclerocornea (HP:0000647) | 1.70246693 |
| 90 | Small hand (HP:0200055) | 1.68675846 |
| 91 | Neonatal respiratory distress (HP:0002643) | 1.68379797 |
| 92 | Clumsiness (HP:0002312) | 1.67566517 |
| 93 | Hypophosphatemic rickets (HP:0004912) | 1.66451560 |
| 94 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.66431537 |
| 95 | Abnormality of the fovea (HP:0000493) | 1.66382900 |
| 96 | Abnormality of renal excretion (HP:0011036) | 1.66350994 |
| 97 | Anencephaly (HP:0002323) | 1.66257281 |
| 98 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.66008767 |
| 99 | Stomach cancer (HP:0012126) | 1.65828063 |
| 100 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.65442993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.57306313 |
| 2 | MAP4K2 | 4.40684973 |
| 3 | TLK1 | 4.23755823 |
| 4 | WNK4 | 3.75552186 |
| 5 | ADRBK2 | 3.06966488 |
| 6 | MAPK15 | 2.98546816 |
| 7 | MAP2K6 | 2.82528280 |
| 8 | BMPR1B | 2.65518799 |
| 9 | ZAK | 2.30323569 |
| 10 | NUAK1 | 2.26460648 |
| 11 | ACVR1B | 2.15088832 |
| 12 | WNK3 | 2.11297447 |
| 13 | TAOK2 | 2.07938776 |
| 14 | TAOK3 | 2.07347344 |
| 15 | GRK1 | 1.84552725 |
| 16 | STK39 | 1.78224156 |
| 17 | SIK2 | 1.76791121 |
| 18 | MUSK | 1.76775398 |
| 19 | CASK | 1.75142060 |
| 20 | PINK1 | 1.75054545 |
| 21 | OXSR1 | 1.74665135 |
| 22 | TRIM28 | 1.64023759 |
| 23 | DAPK2 | 1.63586082 |
| 24 | MAPK13 | 1.50188977 |
| 25 | TXK | 1.45059024 |
| 26 | ADRBK1 | 1.31188159 |
| 27 | MAP3K4 | 1.21178062 |
| 28 | MKNK2 | 1.08689228 |
| 29 | BCKDK | 1.07530966 |
| 30 | TGFBR1 | 0.95822857 |
| 31 | INSRR | 0.95125611 |
| 32 | PRKCI | 0.91490901 |
| 33 | BCR | 0.86387659 |
| 34 | MARK1 | 0.86364649 |
| 35 | MST4 | 0.84587026 |
| 36 | FGFR2 | 0.84234928 |
| 37 | CSNK1G1 | 0.81261509 |
| 38 | PAK3 | 0.80530470 |
| 39 | CSNK1G3 | 0.79685495 |
| 40 | TNIK | 0.79272882 |
| 41 | PHKG2 | 0.76563093 |
| 42 | PHKG1 | 0.76563093 |
| 43 | IKBKB | 0.74335669 |
| 44 | MAPKAPK3 | 0.73541351 |
| 45 | NME1 | 0.72997988 |
| 46 | KIT | 0.69801904 |
| 47 | DYRK2 | 0.68571438 |
| 48 | PIK3CA | 0.67397462 |
| 49 | CSNK1A1L | 0.67149184 |
| 50 | CSNK1G2 | 0.66615544 |
| 51 | PTK2B | 0.66420422 |
| 52 | PRKCG | 0.65016802 |
| 53 | PRKCE | 0.64506250 |
| 54 | TIE1 | 0.61592203 |
| 55 | EIF2AK3 | 0.60964812 |
| 56 | STK3 | 0.59929244 |
| 57 | CAMKK2 | 0.59396079 |
| 58 | MAP2K7 | 0.58202862 |
| 59 | STK11 | 0.58012729 |
| 60 | NEK2 | 0.57964701 |
| 61 | AKT3 | 0.56095037 |
| 62 | MAPKAPK5 | 0.52879154 |
| 63 | VRK2 | 0.49869669 |
| 64 | CSNK1D | 0.47241813 |
| 65 | DYRK3 | 0.47162965 |
| 66 | IRAK1 | 0.46913549 |
| 67 | PRKCQ | 0.46428794 |
| 68 | ERBB3 | 0.45189487 |
| 69 | NTRK3 | 0.45123602 |
| 70 | GRK6 | 0.45027794 |
| 71 | VRK1 | 0.44513929 |
| 72 | PDK2 | 0.42805863 |
| 73 | RPS6KA5 | 0.42705831 |
| 74 | MAP3K5 | 0.42634213 |
| 75 | CSNK1A1 | 0.42399726 |
| 76 | PLK2 | 0.41517744 |
| 77 | MKNK1 | 0.39117000 |
| 78 | PRKAA1 | 0.38483765 |
| 79 | TEC | 0.36561352 |
| 80 | NLK | 0.36097946 |
| 81 | ATR | 0.36018177 |
| 82 | TAF1 | 0.35295359 |
| 83 | GRK5 | 0.33930412 |
| 84 | CHEK2 | 0.33859157 |
| 85 | PRKCZ | 0.33546509 |
| 86 | EPHA4 | 0.32497677 |
| 87 | MARK3 | 0.30451347 |
| 88 | PRKACA | 0.30330586 |
| 89 | SYK | 0.29844366 |
| 90 | ITK | 0.29507155 |
| 91 | TSSK6 | 0.29083936 |
| 92 | SIK3 | 0.28975187 |
| 93 | CAMK2A | 0.28952281 |
| 94 | PLK4 | 0.28029212 |
| 95 | CAMK1 | 0.27368130 |
| 96 | PRKCA | 0.27049187 |
| 97 | IKBKE | 0.26464032 |
| 98 | CAMK1D | 0.26049357 |
| 99 | PKN1 | 0.25080017 |
| 100 | CHUK | 0.24323007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 4.19709405 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.26586009 |
| 3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.11558290 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.81872440 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.54795166 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.47172514 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.25441365 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.25370818 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.11142616 |
| 10 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.06903505 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.99166004 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.96085897 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 1.89595192 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.85660702 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85449695 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.75162634 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.73674596 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.72117091 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69423084 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64129694 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.63234463 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57105644 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.54856236 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53976452 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.52086350 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48398888 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44325474 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.41551741 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.37233651 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.33540058 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28578015 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25525867 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.21645169 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.20310515 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.17169676 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14012453 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.12434597 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09667717 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07872465 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.05597628 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04044891 |
| 42 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03680949 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99940132 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98693041 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97928307 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92302573 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91413061 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90139866 |
| 49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.89938821 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85319401 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82663623 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.80462506 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79188488 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77797473 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75290596 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74565633 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74340090 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74189565 |
| 59 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73801689 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72812582 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70170056 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68572552 |
| 63 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68297302 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.68166148 |
| 65 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62283687 |
| 66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62214709 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62012304 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61627850 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.61237729 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60824152 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60740134 |
| 72 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60605286 |
| 73 | Proteasome_Homo sapiens_hsa03050 | 0.60125333 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.59871348 |
| 75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59586837 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57234555 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56942424 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.55473893 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55417191 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54010486 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53604036 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51928496 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51763357 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51416574 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51332955 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48153722 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46314287 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44843623 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39496861 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39229538 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37310632 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.35565513 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35561217 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34244913 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33044263 |
| 96 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32870483 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29298652 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.29087206 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24646107 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.23387936 |

